Structure |
Chemical Name |
CAS |
MF |
![4-Chloro-2-propylsulfanyl-pyrimidine](/CAS/20180527/GIF/1351990-36-7.gif) |
4-Chloro-2-propylsulfanyl-pyrimidine |
1351990-36-7 |
C7H9ClN2S |
![IMp. A (EP): (RS)-2-Chloro-N-(2-Methylphenyl)-PropanaMide](/CAS/20150408/GIF/39084-88-3.gif) |
IMp. A (EP): (RS)-2-Chloro-N-(2-Methylphenyl)-PropanaMide |
39084-88-3 |
C10H11Cl2NO |
![benzyl (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate](/CAS/20200611/GIF/1194550-67-8.gif) |
benzyl (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate |
1194550-67-8 |
C36H30Cl2N2O7S |
![Cabozantinib impurity 75](/) |
Cabozantinib impurity 75 |
|
|
![1β-Hydroxy-6α-Methyl-1,4-androstadiene-3,17-dione](/CAS/GIF/61919-52-6.gif) |
1β-Hydroxy-6α-Methyl-1,4-androstadiene-3,17-dione |
61919-52-6 |
C20H26O3 |
![D-Proline, 1-[(2S)-3-mercapto-2-methyl-1-oxopropyl]-](/CAS/20180528/GIF/119238-52-7.gif) |
D-Proline, 1-[(2S)-3-mercapto-2-methyl-1-oxopropyl]- |
119238-52-7 |
C9H15NO3S |
![2,4(1H,3H)-Pyrimidinedione,5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2S-cis)- (9CI)](/CAS/20200119/GIF/145281-92-1.gif) |
2,4(1H,3H)-Pyrimidinedione,5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2S-cis)- (9CI) |
145281-92-1 |
C8H9FN2O4S |
![Cyclopentanecarboxylic acid, 1-[(1-oxopentyl)amino]-](/CAS/20180529/GIF/15026-80-9.gif) |
Cyclopentanecarboxylic acid, 1-[(1-oxopentyl)amino]- |
15026-80-9 |
C11H19NO3 |
![Cabozantinib impurity 73](/) |
Cabozantinib impurity 73 |
|
|
![L-Phenylalanine, N-L-leucyl-, methyl ester](/CAS/20180529/GIF/38155-18-9.gif) |
L-Phenylalanine, N-L-leucyl-, methyl ester |
38155-18-9 |
C16H24N2O3 |
![5-Fluoro ent-LaMivudine Acid D-Menthol Ester](/CAS/GIF/764659-79-2.gif) |
5-Fluoro ent-LaMivudine Acid D-Menthol Ester |
764659-79-2 |
C18H26FN3O4S |
![Ethanol, 2-[(2-chloroethyl)amino]-](/CAS/20180529/GIF/3890-98-0.gif) |
Ethanol, 2-[(2-chloroethyl)amino]- |
3890-98-0 |
C4H10ClNO |
![Canagliflozin Impurity 69](/) |
Canagliflozin Impurity 69 |
|
|
![2-[(2-フリルメチル)アミノ]-5-スルファモイル安息香酸](/CAS/20180531/GIF/4818-85-3.gif) |
2-[(2-フリルメチル)アミノ]-5-スルファモイル安息香酸 |
4818-85-3 |
C12H12N2O5S |
![3,5,7-トリメチル-1-アダマンタンアミン?塩酸塩](/CAS/20150408/GIF/15210-60-3.gif) |
3,5,7-トリメチル-1-アダマンタンアミン?塩酸塩 |
15210-60-3 |
C13H24ClN |
![Dapoxetine impurity 65](/) |
Dapoxetine impurity 65 |
|
|
![Dapoxetine impurity 59](/) |
Dapoxetine impurity 59 |
|
|
![2,6-ジメチル-4-(2,3-ジクロロフェニル)-3,5-ピリジンジカルボン酸3-メチル5-(ブチリルオキシメチル)](/CAS/20150408/GIF/188649-48-1.gif) |
2,6-ジメチル-4-(2,3-ジクロロフェニル)-3,5-ピリジンジカルボン酸3-メチル5-(ブチリルオキシメチル) |
188649-48-1 |
C21H21Cl2NO6 |
![PeraMpanel](/CAS/20210111/GIF/380919-34-6.gif) |
PeraMpanel |
380919-34-6 |
C23H17N3O2 |
![Empagliflozin Impurity 83](/) |
Empagliflozin Impurity 83 |
|
|
![Ambroxol Imp.O](/CAS/20210111/GIF/1807328-39-7.gif) |
Ambroxol Imp.O |
1807328-39-7 |
C13H12Br2N2O |
![Olopatadine Impurity 10 HBr](/CAS/20211123/GIF/4174-83-8.gif) |
Olopatadine Impurity 10 HBr |
4174-83-8 |
C22H26Br2NP |
![Iohexol Impurity Q](/) |
Iohexol Impurity Q |
|
|
![Cefodizime Impurity 2](/) |
Cefodizime Impurity 2 |
|
|
![Choline Fenofibrate Impurity 1](/CAS/20180527/GIF/2985-79-7.gif) |
Choline Fenofibrate Impurity 1 |
2985-79-7 |
C13H9ClO2 |
![4(1H)-Pyridinone, 2-(hydroxymethyl)-3,5-dimethyl- (9CI)](/CAS/GIF/220757-73-3.gif) |
4(1H)-Pyridinone, 2-(hydroxymethyl)-3,5-dimethyl- (9CI) |
220757-73-3 |
C8H11NO2 |
![Rocuronium Bromide Impurity 19 、21、22](/) |
Rocuronium Bromide Impurity 19 、21、22 |
|
|
![Flucloxacillin impurity D](/) |
Flucloxacillin impurity D |
|
|
![Ritonavir EP Impurity STU](/) |
Ritonavir EP Impurity STU |
|
|
![Letermovir Impurity 1](/) |
Letermovir Impurity 1 |
|
|
![Roxadustat Impurity 16](/) |
Roxadustat Impurity 16 |
|
|
![Perospirone Impurity 19](/) |
Perospirone Impurity 19 |
|
|
![Dolutegravir Impurity 14(Sodium Salt)](/) |
Dolutegravir Impurity 14(Sodium Salt) |
|
|
![Fondaparinux sodium impurity 5](/) |
Fondaparinux sodium impurity 5 |
|
|
![Fondaparinux sodium impurity 20](/) |
Fondaparinux sodium impurity 20 |
|
|
![BIS VALACYCLOVIR (?90%)](/CAS/GIF/1356019-51-6.gif) |
BIS VALACYCLOVIR (?90%) |
1356019-51-6 |
C27H40N12O8 |
![Flupirtine DiMer](/CAS/20180808/GIF/1417916-52-9.gif) |
Flupirtine DiMer |
1417916-52-9 |
C30H32F2N8O4 |
![3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide](/CAS/20150408/GIF/CB42658629.gif) |
3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide |
2304623-36-5 |
C16H14N2O3S |
![(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(M-tolyl)propan-1-aMine](/CAS/20150408/GIF/253337-60-9.gif) |
(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(M-tolyl)propan-1-aMine |
253337-60-9 |
C22H25N |
![3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide](/CAS/20150408/GIF/CB42666835.gif) |
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide |
1675248-19-7 |
C16H22N6O2 |
![Blonanserin iMpurity](/CAS/20180808/GIF/132810-83-4.gif) |
Blonanserin iMpurity |
132810-83-4 |
C23H30FN3 |
![Deferasirox iMpurity](/CAS/20210111/GIF/1688656-83-8.gif) |
Deferasirox iMpurity |
1688656-83-8 |
C42H28N6O8S |
![Lercanidipine iMpurity](/CAS/20210111/GIF/320750-19-4.gif) |
Lercanidipine iMpurity |
320750-19-4 |
C37H43N3O6 |
![AMpicillin EP IMpurity J](/CAS/20200515/GIF/6489-58-3.gif) |
AMpicillin EP IMpurity J |
6489-58-3 |
C13H20N2O4S |
![CefathiaMidine Lactone](/CAS/20180808/GIF/905712-22-3.gif) |
CefathiaMidine Lactone |
905712-22-3 |
C17H24N4O4S2 |
![Cinacalcet IMpurity 9](/CAS/20211123/GIF/802918-36-1.gif) |
Cinacalcet IMpurity 9 |
802918-36-1 |
C22H24F3N |
![Doxorubicin IMpurity B](/CAS/20210111/GIF/106401-68-7.gif) |
Doxorubicin IMpurity B |
106401-68-7 |
C29H34BrNO11 |
![EzetiMibe IMpurity B](/) |
EzetiMibe IMpurity B |
|
|
![Fluconazole IMpurity [1, 3-Bis(1H-1, 2, 4-Triazole-1-yl)propan-2-one]](/CAS/20150408/GIF/CB42674319.gif) |
Fluconazole IMpurity [1, 3-Bis(1H-1, 2, 4-Triazole-1-yl)propan-2-one] |
1449785-88-9 |
C10H7F2N3O |
![HydroxyMethylidene thione](/CAS/20150408/GIF/1320360-86-8.gif) |
HydroxyMethylidene thione |
1320360-86-8 |
C15H18N4OS |
![Lansoprazole IMpurity I](/) |
Lansoprazole IMpurity I |
|
|
![Lapatinib IMpurity 10](/CAS/20200515/GIF/1152131-73-1.gif) |
Lapatinib IMpurity 10 |
1152131-73-1 |
C26H17ClFN3O4 |
![Metronidazole IMpurity D](/) |
Metronidazole IMpurity D |
|
|
![PraMipexole IMpurity V (PraMipexole IMpurity Z)](/) |
PraMipexole IMpurity V (PraMipexole IMpurity Z) |
|
|
![Linagliptin Impurity S](/CAS/20180808/GIF/668273-74-3.gif) |
Linagliptin Impurity S |
668273-74-3 |
C30H36N8O4 |
![(R)-2-((6-(3-aminopiperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile](/CAS/20180629/GIF/CB03042203.gif) |
(R)-2-((6-(3-aminopiperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile |
|
C17H18FN5O2 |
![Olaparib impurity 1](/CAS/20180629/GIF/763113-06-0.gif) |
Olaparib impurity 1 |
763113-06-0 |
C24H24N4O3 |
![4-Quinazolinamine,N-(3-ethenylphenyl)-6,7-bis(2-methoxyethoxy)-,hydrochloride(1:1)](/CAS/20180808/GIF/1624294-38-7.gif) |
4-Quinazolinamine,N-(3-ethenylphenyl)-6,7-bis(2-methoxyethoxy)-,hydrochloride(1:1) |
1624294-38-7 |
C22H26ClN3O4 |
![4-Oxiranylmethoxy-benzaldehyde](/CAS/20180629/GIF/14697-49-5.gif) |
4-Oxiranylmethoxy-benzaldehyde |
14697-49-5 |
C10H10O3 |
![Etoricoxib Impurity 15](/CAS/20180906/GIF/73312-69-3.gif) |
Etoricoxib Impurity 15 |
73312-69-3 |
C5H8ClNO |
![Ibrutinib Impurity 1](/) |
Ibrutinib Impurity 1 |
|
|
![Mirabegron Impurity 13](/) |
Mirabegron Impurity 13 |
|
|
![Riociguat Impurtiy 4](/) |
Riociguat Impurtiy 4 |
|
|
![Cabozantinib Impurity](/CAS/20210111/GIF/1355031-15-0.gif) |
Cabozantinib Impurity |
1355031-15-0 |
C16H14N2O3 |
![Canagliflozin open-ring impurity](/) |
Canagliflozin open-ring impurity |
|
|
![Dapoxetine Impurity E](/) |
Dapoxetine Impurity E |
|
|
![Linagliptin Impurity X](/) |
Linagliptin Impurity X |
|
|
![Norfloxacin Imp.(EP)](/CAS/20200611/GIF/1911573-08-4.gif) |
Norfloxacin Imp.(EP) |
1911573-08-4 |
C34H52FN3O4 |
![Rocuronium Bromide Impurity](/CAS/20211123/GIF/13492-57-4.gif) |
Rocuronium Bromide Impurity |
13492-57-4 |
C27H44N2O4 |
![Ruxolitinib Impurity](/) |
Ruxolitinib Impurity |
|
|
![Roxithromycin h](/) |
Roxithromycin h |
|
|
![Ixazomib Impurity 2](/) |
Ixazomib Impurity 2 |
|
|
![sildenafil impurity I](/CAS/20180629/GIF/CB03054710.gif) |
sildenafil impurity I |
|
C22H30N6O4S |
![4-(benzyloxy)-2-methyl-1H-benzo[d]imidazole-6-carboxylic acid](/CAS/20180629/GIF/942195-83-7.gif) |
4-(benzyloxy)-2-methyl-1H-benzo[d]imidazole-6-carboxylic acid |
942195-83-7 |
C16H14N2O3 |
![Tofacitinib Impurity G](/) |
Tofacitinib Impurity G |
|
|
![Ceftaroline Fosamil Impurity 6](/CAS/20211123/GIF/953037-71-3.gif) |
Ceftaroline Fosamil Impurity 6 |
953037-71-3 |
C22H20N8O5S4 |
![DecitaBine Impurity 11](/) |
DecitaBine Impurity 11 |
|
|
![Isavuconazole Impurity 21](/) |
Isavuconazole Impurity 21 |
|
|
![Isavuconazole Impurity 27](/) |
Isavuconazole Impurity 27 |
|
|
![Istradefylline Impurity E](/) |
Istradefylline Impurity E |
|
|
![Linagliptin Impurity 41](/) |
Linagliptin Impurity 41 |
|
|
![PalBociclib Impurity 17](/) |
PalBociclib Impurity 17 |
|
|
![PalBociclib Impurity 24](/) |
PalBociclib Impurity 24 |
|
|
![Posaconazole Impurity 12](/) |
Posaconazole Impurity 12 |
|
|
![Posaconazole Impurity 24](/CAS/20211123/GIF/165115-78-6.gif) |
Posaconazole Impurity 24 |
165115-78-6 |
C19H20F2O2 |
![Sitagliptin Impurity 24](/CAS/20210111/GIF/2349567-54-8.gif) |
Sitagliptin Impurity 24 |
2349567-54-8 |
C15H19F2NO4 |
![Tamoxifen EP Impurity H](/CAS/20180527/GIF/809285-09-4.gif) |
Tamoxifen EP Impurity H |
809285-09-4 |
C43H48N2O2 |
![Tenofovir impurity Q](/) |
Tenofovir impurity Q |
|
|
![Trelagliptin Impurity 20](/CAS/20210111/GIF/1821520-42-6.gif) |
Trelagliptin Impurity 20 |
1821520-42-6 |
C20H22FN5O3 |
![Umeclidinium Impurity 3](/CAS/20211123/GIF/869113-45-1.gif) |
Umeclidinium Impurity 3 |
869113-45-1 |
C29H32BrNO3 |
![Vardenafil Impurity 7](/CAS/20200611/GIF/448184-56-3.gif) |
Vardenafil Impurity 7 |
448184-56-3 |
C21H26N6O7S |
![Moxifloxacin Related Compound A (HCl salt form)](/CAS/20211123/GIF/151282-23-4.gif) |
Moxifloxacin Related Compound A (HCl salt form) |
151282-23-4 |
C20H22ClF2N3O3 |
![8-Hydroxy Entecavir](/CAS/20210111/GIF/1795791-10-4.gif) |
8-Hydroxy Entecavir |
1795791-10-4 |
C12H15N5O4 |
![1-Pyrrolidinecarboxylic acid, 4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4R)-](/CAS/20180527/GIF/1404559-22-3.gif) |
1-Pyrrolidinecarboxylic acid, 4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4R)- |
1404559-22-3 |
C27H38N6O3S |
![Ampicillin Impurity A](/) |
Ampicillin Impurity A |
|
|
![Oxacillin Sodium Impurity B(EP)](/) |
Oxacillin Sodium Impurity B(EP) |
|
|
![3,5-dichlorothiophene-2-carboxylic acid](/CAS/20180527/GIF/89166-94-9.gif) |
3,5-dichlorothiophene-2-carboxylic acid |
89166-94-9 |
C5H2Cl2O2S |
![Brexpiprazole Impurity 2](/CAS/20200611/GIF/2094559-58-5.gif) |
Brexpiprazole Impurity 2 |
2094559-58-5 |
C38H40N4O4S |
![2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carboxylic acid](/CAS/20180527/GIF/80047-38-7.gif) |
2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carboxylic acid |
80047-38-7 |
C12H10N2O3 |
![Levofloxacin Impurity 7](/CAS/20180527/GIF/1607796-83-7.gif) |
Levofloxacin Impurity 7 |
1607796-83-7 |
C15H14FNO5 |